The FDA is poised to decide whether to approve aducanumab, a drug to treat Alzheimer’s. It’s proved highly effective at removing the sticky amyloid plaques associated with the disease from the brain.
- Sports Psychologist Kanyali Ilako On How To Treat Athletes’ Mental Health
- Want To Mix 2 Different COVID-19 Vaccines? Canada Is Fine With That